Highlights Viral suppression improved after introducing a dolutegravir-based regimen. HIV viral loads <50 copies/mL were lower than expected (<90%). Higher viral suppression was found when antiretroviral therapy adherence/alterations were controlled (per-protocol analysis). Some baseline characteristics can influence the effectiveness of first-line antiretroviral therapy. ABSTRACT Objective To compare viral suppression in treatment-naïve adults starting antiretroviral therapy with dolutegravir (50mg)- and efavirenz (600mg)-based regimens. Methods We analyzed secondary data from Brazilian health information systems of people living with human immunodeficiency virus who […]

ABSTRACT Objective: To characterize the sociodemographic profile of the population undergoing antiretroviral treatment in the state of Paraná, Brazil, to investigate the proportion of people undergoing treatment among all those diagnosed, and to analyze the proportion of patients with suppressed viral load in different regions of the state. Methods: Observational descriptive and analytical study carried out with information referring to the period from January 2018 to January 2019. Data were obtained from the Sistema Informatizado de Monitoramento Clínico das Pessoas […]